N95 Face Masks Get Pathogen Killing Technology with Addition of New UVC Medical Device
By HospiMedica International staff writers Posted on 24 Jun 2020 |
Illustration
A new low-cost UVC medical device adds pathogen killing technology for N95 face masks that is effective on COVID-19.
N95 masks act as a barrier to help prevent the spread of pathogens in droplets from being exhaled and inhaled, but do not provide the capability to kill pathogens. The technology developed by Brite-Strike Technologies Inc. (Duxbury, MA, USA) adds this critical component to N95 masks. The micro device can be installed in any N95 in seconds and can also be used in conjunction with hydrogen peroxide and a heat source to decontaminate a single user N95 mask in the field.
The company, which holds numerous patents related to LED light in visible, IR (infrared) and UV (ultraviolet) light as well as UV light for sterilization of air and water, has received FDA Pre-EAU approval to begin testing the device.
Related Links:
Brite-Strike Technologies Inc.
N95 masks act as a barrier to help prevent the spread of pathogens in droplets from being exhaled and inhaled, but do not provide the capability to kill pathogens. The technology developed by Brite-Strike Technologies Inc. (Duxbury, MA, USA) adds this critical component to N95 masks. The micro device can be installed in any N95 in seconds and can also be used in conjunction with hydrogen peroxide and a heat source to decontaminate a single user N95 mask in the field.
The company, which holds numerous patents related to LED light in visible, IR (infrared) and UV (ultraviolet) light as well as UV light for sterilization of air and water, has received FDA Pre-EAU approval to begin testing the device.
Related Links:
Brite-Strike Technologies Inc.
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans